Skip to content
PICO Portalanswers from OpenAlex

Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis

PaperCitations, authors & open-access status

Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis is a paper indexed in PICO Portal from OpenAlex.

How many citations does Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis have?

PICO Portalcitation count

Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis has 21 citations in the OpenAlex counts PICO Portal stores.

When was Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis published?

PICO Portalyear

Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis has 2022 year in the PICO Portal index.

What is the open-access status of Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis?

PICO Portaloa status

Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis has gold oa status in the PICO Portal index.

What is the DOI of Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis?

PICO Portaldoi

The DOI for Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis is on the source record.

What is the PMID of Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis?

PICO Portalpmid

The PMID for Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis is on the source record.

What is the OpenAlex record for Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis?

PICO Portalopenalex

The OpenAlex for Clinical manifestation, economic burden, and mortality in patients with transthyretin cardiac amyloidosis is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial